These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 11676549)

  • 1. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts.
    Green DW; Roh H; Pippin JA; Drebin JA
    J Surg Res; 2001 Nov; 101(1):16-20. PubMed ID: 11676549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells.
    Roh H; Green DW; Boswell CB; Pippin JA; Drebin JA
    Cancer Res; 2001 Sep; 61(17):6563-8. PubMed ID: 11522655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
    Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
    Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Icat induces G(2) arrest and cell death in tumor cell mutants for adenomatous polyposis coli, beta-catenin, or Axin.
    Sekiya T; Nakamura T; Kazuki Y; Oshimura M; Kohu K; Tago K; Ohwada S; Akiyama T
    Cancer Res; 2002 Jun; 62(11):3322-6. PubMed ID: 12036951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells.
    Verma UN; Surabhi RM; Schmaltieg A; Becerra C; Gaynor RB
    Clin Cancer Res; 2003 Apr; 9(4):1291-300. PubMed ID: 12684397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of a novel human gene, DRCTNNB1A, the expression of which is down-regulated by beta-catenin.
    Kawasoe T; Furukawa Y; Daigo Y; Nishiwaki T; Ishiguro H; Fujita M; Satoh S; Miwa N; Nagasawa Y; Miyoshi Y; Ogawa M; Nakamura Y
    Cancer Res; 2000 Jul; 60(13):3354-8. PubMed ID: 10910037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mammalian two-hybrid system for adenomatous polyposis coli-mutated colon cancer therapeutics.
    Wakita K; Tetsu O; McCormick F
    Cancer Res; 2001 Feb; 61(3):854-8. PubMed ID: 11221869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of beta catenin inhibits the growth of esophageal carcinoma cells.
    Veeramachaneni NK; Kubokura H; Lin L; Pippin JA; Patterson GA; Drebin JA; Battafarano RJ
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):92-8. PubMed ID: 14752418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers.
    Vécsey-Semjén B; Becker KF; Sinski A; Blennow E; Vietor I; Zatloukal K; Beug H; Wagner E; Huber LA
    Oncogene; 2002 Jul; 21(30):4646-62. PubMed ID: 12096341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
    Ramachandran C; Wellham LL
    Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
    Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of monocyte chemotactic protein-3 by activated beta-catenin.
    Fujita M; Furukawa Y; Nagasawa Y; Ogawa M; Nakamura Y
    Cancer Res; 2000 Dec; 60(23):6683-7. PubMed ID: 11118053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of a novel human gene, APCDD1, as a direct target of the beta-Catenin/T-cell factor 4 complex with probable involvement in colorectal carcinogenesis.
    Takahashi M; Fujita M; Furukawa Y; Hamamoto R; Shimokawa T; Miwa N; Ogawa M; Nakamura Y
    Cancer Res; 2002 Oct; 62(20):5651-6. PubMed ID: 12384519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence for involvement of beta-catenin and APC in urothelial carcinomas.
    Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A
    Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice.
    Aharinejad S; Abraham D; Paulus P; Abri H; Hofmann M; Grossschmidt K; Schäfer R; Stanley ER; Hofbauer R
    Cancer Res; 2002 Sep; 62(18):5317-24. PubMed ID: 12235002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of beta-catenin by antisense oligomers augments tumor response to isolated limb perfusion in a rodent model of adenomatous polyposis coli-mutant colon cancer.
    Canter RJ; Kesmodel SB; Heitjan DF; Veeramachaneni NK; Mokadam NA; Drebin JA; Fraker DL
    Ann Surg Oncol; 2005 Sep; 12(9):733-42. PubMed ID: 16132380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The suppression of colon cancer cell growth in nude mice by targeting beta-catenin/TCF pathway.
    Kwong KY; Zou Y; Day CP; Hung MC
    Oncogene; 2002 Nov; 21(54):8340-6. PubMed ID: 12447697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APC truncation and increased beta-catenin levels in a human breast cancer cell line.
    Schlosshauer PW; Brown SA; Eisinger K; Yan Q; Guglielminetti ER; Parsons R; Ellenson LH; Kitajewski J
    Carcinogenesis; 2000 Jul; 21(7):1453-6. PubMed ID: 10874025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression.
    Shih IM; Yu J; He TC; Vogelstein B; Kinzler KW
    Cancer Res; 2000 Mar; 60(6):1671-6. PubMed ID: 10749138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.